Nafoxidine hydrochloride (Upjohn, 11 100A) injected with oestradiol into immature chicks inhibits the hormone-induced increase in [3H]oestradiol-binding activity in salt extracts of liver nuclei as well as the subsequent production by liver of egg-yolk phosphoprotein. No differences in the properties of the oestradiol-binding activity in extracts from nafoxidine-treated chicks or from oestradiol-treated chicks were detected. Chick liver cytosol does not contain detectable high-affinity oestradiol-binding activity. A low-affinity oestradiol-binding component with a sedimentation coefficient of 3.5S was found, but it was unaffected by treatment of chicks with either nafoxidine or oestradiol. The results suggest a difference in the mechanism of oestradiol action in the chick liver and in the widely studied rat uterus, on which the usual model for oestradiol action is largely based.
is 43 nm, which indicates an affinity of nafoxidine for the binding protein about 4 % of that of oestradiol. The inhibitory action of nafoxidine in vivo thus is more potent than the relative binding affinity determined in vitro might indicate. One possible explanation is that the primary site of nafoxidine action is at a point proximal to nuclear receptor interaction. Nafoxidine injected alone into the chick does not induce phosphoprotein synthesis, but it does increase [3H] oestradiol-binding activity in extracts of liver nuclei to a limited extent.
No differences in the properties of the oestradiol-binding activity in extracts from nafoxidine-treated chicks or from oestradiol-treated chicks were detected. Chick liver cytosol does not contain detectable high-affinity oestradiol-binding activity. A low-affinity oestradiol-binding component with a sedimentation coefficient of 3.5S was found, but it was unaffected by treatment of chicks with either nafoxidine or oestradiol. The results suggest a difference in the mechanism of oestradiol action in the chick liver and in the widely studied rat uterus, on which the usual model for oestradiol action is largely based.
Non-steroidal anti-oestrogens have been useful probes in the investigation of the mechanism of action of oestradiol. Some of the earliest indications of the physiological relevance of oestradiol-cytosol receptor interaction came from experiments with anti-oestrogens (Jensen, 1966) . These and other studies resulted in the current model for oestradiol action in the mammalian uterus, in which the hormone initially binds a specific high-affinity cytosol receptor, the complex undergoes a transformation from a 4S to a 5S species and migrates to the nucleus, where it interacts with specific acceptor sites in the chromatin and stimulates specific transcriptional events (Jensen et al., 1974; O'Malley & Means, 1974) .
The anti-oestrogen nafoxidine hydrochloride (1 -{2 -[p -(3,4 -dihydro -6 -methoxy -2 -phenyl -1 -naphthyl)phenoxy]ethyl}pyrrolidine hydrochloride; Upjohn 11100A) is a diphenyldihydronaphthalene derivative which has been widely used in mammalian systems (Jensen & DeSombre, 1973) . It binds both the cytoplasmic and nuclear forms of oestradiol receptor in rat uterus (Rochefort et al., 1972a) . It exhibits both agonistic and antagonistic effects in rat uterus, and recent work suggests that a site of the antagonistic action is in the blockage or delay in replenishment of the cytoplasmic oestrogen receptor (Clark et al., 1974; Katzenellenbogen & Ferguson, 1975; Capony & Rochefort, 1975) . Vol. 164 In the chick liver, oestradiol induces the formation ofthe egg-yolk phosphoprotein precursor vitellogenin (Clemens, 1974; Deeley et al., 1975) . Particular interest in the mechanism of oestradiol action in this tissue derives from the fact that, with one exception (Arias & Warren, 1971) , no groups have been able to demonstrate the presence of a typical high-affinity cytosol receptor for oestradiol (Mester & Baulieu, 1972; Ozon & Bell6, 1973; Lazier, 1975) . They were, however, able to show specific high-affinity binding of oestradiol in salt extracts of liver nuclei. Such activity is also present in an insoluble nuclear residue (Lebeau et al., 1974) and in chromatin (Gschwendt & Kittstein, 1974) . Treatment of immature chicks or of roosters with oestradiol results in a substantial increase in each of these binding activities preceding the production of vitellogenin. Rooster liver cytosol contains only a low-affinity binding protein for oestradiol (Gschwendt, 1975a) .
Studies on anti-oestrogen action in chick liver were thus undertaken in an attempt to clarify the apparent difference in the interaction of oestradiol in this tissue and in the rat uterus. Indeed, two reports show that nafoxidine is anti-oestrogenic in a single injection in the chick and is not itself oestrogenic (Gschwendt, 1975b; Lazier, 1975) . This contrasts with the situation in the rat (Clark et al., 1974) . Gschwendt (1975b) noted the inhibitory action of nafoxidine on the rooster liver oestradiol-binding sites in chromatin. Here we examine the effect of nafoxidine in the presence or absence of oestradiol on the salt-soluble nuclear oestradiol-binding activity. Preliminary abstracts dealing with some of the findings have been presented elsewhere (Lazier & Alford, 1975 , 1976b 
Animals and injections
Male Cobb chicks (1-3 weeks old) were obtained from a local hatchery. Oestradiol, puromycin and nafoxidine were all dissolved in propylene glycol for injection (intraperitoneally) at concentrations of 25, 25 and 50mg/ml respectively. Doses were 2.5mg/ lOOg body wt. for oestradiol, 2.5mg/1OOg for puromycin and 5.0mg/lOOg for nafoxidine, unless otherwise indicated.
Preparation of cell extracts
The crude nuclear pellet was prepared by centrifugation in sucrose-containing buffers (A and B) as described previously (Lazier, 1975) . Nuclear extracts for sucrose-gradient centrifugation were prepared in the same buffers supplemented with thioglycerol (10mM) as recommended by Harrison & Toft (1975) . This did not appear to affect the activity or stability of [3H]oestradiol binding.
The washed crude nuclear pellets were homogenized in buffer C (0.5M-KCI/1.5mM-EDTA/lOmMTris/HCI, pH17.4) (1 g of tissue/ml). DNA in the nuclear homogenate was determined by the method of Burton (1970) and is expressed as umol of nucleotide. The homogenate was frozen for at least 1 h at -20°C, thawed and centrifuged at 37000g for 30min. The supernatant thus obtained is the nuclear extract. Washing the nuclear pellet with Triton X-100 solutions did not affect the yield of oestradiol-binding activity (per unit of DNA), indicating that the saltsoluble binder is actually located in the nuclei (BestBelpomme et al., 1975) .
Cytosol was prepared by centrifugation of the initial 700g supernatant at lOOOOOg for 1 h.
Determination of [3H]oestradiol binding
All cell extracts were preincubated with an equal volume of charcoal-dextran suspension (0.25 % Norit A, 0.0025% dextran in lOmM-Tris/HCI/1.5 mM-EDTA, pH7.4) for 30min at 37°C. Lazier (1975) showed that this treatment was necessary in extracts from oestradiol-treated chicks to expose specific sites for assay subsequently by incubation with [3H]oestradiol at 2°C. Rochefort et al. (1972a) The procedures were exactly as described pre- viously (Lazier, 1975) .
Sucrose-gradient centrifugation
Sucrose (5-20 %, w/v) gradients were prepared in 4.Oml polypropylene tubes (Martin & Ames, 1961) . Stock solutions (0.5 and 28%, w/v) of sucrose in 10nm4 -Tris/HCI/1 mm -EDTA/lOmM -thioglycerol, pH 7.5, were used to prepared low-salt gradients by using a Buchler gradient former. High-salt gradients were prepared by including 0.5M-KCI in both of the stock sucrose solutions. Cytosol (0.3ml), incubated for 30min at 2°C with 1 nM-[3H]oestradiol, was layered on the gradient, which was then centrifuged in a Spinco SW. 56 rotor at 40000rev./min for 16h. Fractions (two drops each) were obtained by piercing the bottom of the tube. The fractions were added to Aquasol and radioactivity was determined as described above.
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Sucrose gradients were also prepared from high-or low-salt stock sucrose solutions which contained [3H]oestradiol (1 nM). Samples (0.2 ml) of nuclear extract were layered on the gradient, and centrifugation and collection of fractions were as described for conventional gradients. Bound [3H]oestradiol in the fractions was determined by the charcoal-adsorption technique used by Harrison & Toft (1975) . Charcoaldextran suspension (0.4ml) was added to each fraction, and after 1 min at 2°C the mixture was centrifuged at 3000g for 10min. The charcoal-dextran suspension was more concentrated (0.5% charcoal, 0.05 % dextran) than that used in other experiments reported here, and the exposure time to charcoal was briefer ( min). However, preliminary experiments showed that the same amount of specific [3H]oestradiol binding was measured by the two techniques.
Sedimentation values were determined by comparison with an internal 14C-labelled bovine serum albumin marker (Martin & Ames, 1961) prepared by the method of Rice & Means (1971) .
Results
Nafoxidine inhibition ofoestradiol-induced [3H]oestradiol binding and ofphosphoprotein production Table 1 shows the inhibitory effect of nafoxidine given intraperitoneally with oestradiol in several dose combinations on the hormone-induced increase in [3H]oestradiol-binding activity in salt extracts of nuclei and on phosphoprotein production. The dose of oestradiol is similar to that found necessary for induction of phosphoprotein production by other investigators (Beuving & Gruber, 1971; Gschwendt & Kittstein, 1974; Deeley et al., 1975) . Table 1 (a) shows that nafoxidine given in a dose twice that of oestradiol (w/w, or 1.2:1 on a molar basis) almost completely inhibited both responses at the times examined. With the maximum effective dose of oestradiol (10mg/ lOOg; Lazier, 1975) , 50% inhibition of phosphoprotein production at 64h was seen with an equal dose of nafoxidine (w/w, or a molar ratio of nafoxidine to oestradiol of 0.6:1) (Table lb) . This contrasts with the usual doses required in the uterus, where antioestrogen/hormone molar ratios of 25-50 are generally used (Clark et al., 1974; Katzenellenbogen & Ferguson, 1975 Table 2 shows that Kl-versus a single dose of puromycin 1 h before nafoxidine partly inhibited the effect of nafoxidine. Two doses of puromycin, 1 h before and 1Oh after nafoxidine, were inhibitory, but a single dose of puromycin 10h after nafoxidine was ineffective. Thus protein synthesis line for the remay be important early in the response of chick liver 1diol. This conto nafoxidine.
trasts sharply with the inhibitory potency of nafoxidine in vivo (see Table 1 ).
Effects ofnafoxidine alone: time-coursefor the increase in [3H]oestradiol-binding activity and the effect of puromycin As was apparent in Table 1 and has been shown earlier (Lazier, 1975; Gschwendt, 1975b) , nafoxidine itself does not induce phosphoprotein production. However, given in vivo it does result in a small but significant increase in [3H]oestradiol binding in liver nuclear extracts. Fig. 2 shows the extent of the increase in extracts prepared at various times after nafoxidine injection. A comparable dose of oestradiol gave a much earlier and more extensive increase in nuclear-binding activity (Lazier, 1975 (Mester & Baulieu, 1972; Ozon & Belle, 1973; Lazier, 1975 Oestradiol-17awaslesseffectivethanoestradiol-17,6at a concentration of IOnM. The partial competition by oestradiol-17a has been observed earlier (Mester & Baulieu, 1972 Harrison & Toft (1975) to give superior resolution of the oestradiol receptor from chick oviduct cytosol when compared with conventional sucrose gradients. Fig. 3 shows that both types of extract in high-salt gradients exhibit specific [3H]oestradiol-binding activity with a sedimentation coefficient of 4.5S. In low-salt gradients a loss of about 30 % of the activity in the 4.5 S peak was seen for extracts from oestradiol-treated and nafoxidinetreated chicks (Lazier & Alford, 1976a) . No other binding species appear, in contrast with the typical aggregation of the 5 S nuclear uterine oestradiol receptor to an 8-1OS species in low-salt conditico (Alberga et al., 1970) .
The temperature-sensitivity of the [3Hoeotradiolb binding activity was compared in both types of extract (Fig. 4) . Similar inactivation curves were seen for both cases, with a half-life of 5 min at about 55°C. Fig. 5 shows conventional sucrose-gradient profiles for liver cytosol from control chicks and from chicks that had been given nafoxidine or oestradiol 20h previously. In rat uterus, exposure to nafoxidine for 23 h results in marked depletion of the cytosol oestradiol receptor (Clark et al., 1974) . In the chick liver, however, injection of neither nafoxidine nor o=tr4chQl had any 1977 cytosol (0.6ml) in the absence and presence of several concentrations of unlabelled oestradiol (o) or nafoxidine (-) was measured by the charcoal adsorption assay. Cytosol was prepared from 7-day-old chicks unexposed to exogenous oestradiol and was not preincubated with charcoal-dextran. Prior removal of endogenous steroids by charcoal-dextran incubation as described in the Materials and Methods section made no difference to the results. Each point represents the mean ±S.E.M. for triplicate determinations on three preparations. apparent effect on the low-affinity oestradiol-binding protein of cytosol.
The effect of nafoxidine and of unlabelled oestradiol-171i on cytosol binding of [3H] oestradiol was Vol. 164 tested in a charcoal adsorption assay. Fig. 6 shows that very high concentrations of oestradiol-17f, suppressed binding of 2nM-[3H]oestradiol by cytosol. The concentration required to give 50% inhibition was 35/pM. Nafoxidine was even less effective than oestradiol-17,B; 250pM was required to give 50% inhibition.
Discussion
The inhibitory action of nafoxidine on oestradiolinduced vitellogenin synthesis by chick liver has been observed when nafoxidine is given with oestradiol (Lazier, 1975) or 30min before the hormone (Gschwendt, 1975b) . We have taken serum phosphoprotein P content as a measure of vitellogenin synthesis, whereas Gschwendt (1975b) examined the vitellogenin protein by electrophoresis. Gschwendt (1975b) found that nafoxidine decreased the oestradiol stimulation of oestradiol-binding activity of isolated chromatin, and we show here that the anti-oestrogen also inhibits the oestradiol stimulation of the saltsoluble nuclear oestradiol-binding activity. Although the drug itself is not oestrogenic, its anti-oestrogenic potency is very marked, 50 % inhibition of phosphoprotein synthesis being obtained by an anti-oestrogen/oestrogen molar ratio of about 0.6, by using the maximum effective dose of oestradiol. It is noteworthy that with this dose ratio, little inhibition of nuclear oestradiol-binding activity was seen at 24h, but at 48 and 64h the activity fell markedly. This suggests that nuclear receptor must be maintained in an adequate amount over a sustained period of time in order for a full phosphoprotein response to be obtained. Gschwendt (1975b) (Lazier, 1975 Lazier (1975) postulated that the increase in nuclear oestrogen receptor was an obligatory early action in the vitellogenic response in chick liver. The increase (at 1 Ih) was sensitive to actinomycin D and cycloheximide. Delaying the increase (with cycloheximide) resulted in a corresponding delay in phosphoprotein production. Both the extent of the phosphoprotein response and the increase in nuclear oestradiolbinding activity were proportional to the dose of oestradiol. Schneider & Gschwendt (1976) suggest that oestradiol treatment of roosters gives a rapid rise in soluble nuclear receptor (at 10min), followed by a decline and a second rise at 20min. The second rise was inhibited by cycloheximide. Joss et al. (1976) have demonstrated a very rapid rise in nuclear receptor, after injection of oestradiol via the portal vein, which was largely (but not completely) sensitive to cycloheximide. These experiments, and ours, agree in the important point that a stage dependent on protein synthesis is required to give the increase in nuclear oestrogen receptor, well before any vitellogenin production can be demonstrated by a very sensitive radio-isotopic technique (Bergink et al., 1973) . The mechanism for the increase in nuclear receptor could reflect synthesis of new receptor protein, or it could reflect an activation mechanism in which receptor was cleaved from a pre-receptor form by a rapidly turningover peptidase. A small part of the increase may be accounted for by translocation of receptor from an unknown cell compartment.
Our data show that nafoxidine interferes with the oestradiol-induced increase in nuclear receptor content. The mechanism of nafoxidine inhibition appears to be more complex than solely direct blockade of the nuclear oestradiol-binding sites. This follows from our observation that the measured affinity of nafoxidine for the nuclear receptor in vitro is substantially less than that of oestradiol, whereas potent inhibition in vivo is obtained with equimolar doses of the drug and the hormone. The same discrepancy in the potency of nafoxidine in vivo and in vitro is apparent in the results of Gschwendt (1975b) for the effect of the drug on the oestradiol-binding sites in rooster liver chromatin. These observations can be explained in several ways. If the anti-oestrogenic action of the drug is in fact by competitive blockade of nuclear binding sites, it may be that much higher concentrations of nafoxidine relative to oestradiol are achieved in the liver cell through a difference in absorption or metabolism of the two compounds. It is also possible that nafoxidine is metabolized to a more potent inhibitor in vivo. An alternative explanation is that the primary site of nafoxidine action is not on the nuclear receptor itself, but at some point proximal to the nuclear receptor. Thus nafoxidine may interact with a pre-nuclear receptor present in some cell fraction other than the salt extract of nuclei, which has an affinity for nafoxidine equal to or greater than that of oestradiol. The nafoxidine-pre-nuclear receptor complex could not give the increase in nuclear receptor content as readily as can the oestradiol-pre-nuclear receptor complex. Nafoxidine itself therefore would give rise only to a limited amount of nuclear receptor but when given in vivo with oestradiol, the strong inhibitory effect of the drug would be obtained. A search for such a pre-nuclear receptor would be greatly facilitated by the use ofradioactive nafoxidine, as would studies on the absorption, transport and metabolism of the drug. The competition studies reported here indicate that the putative pre-nuclear receptor is not present as a stable entity in cytosol.
Another consideration is that nafoxidine could exert additional inhibitory mechanisms not related to the receptor system.
In rat uterus, the mediation of the oestradiol response by high-affinity cytosol receptor is widely recognized (Jensen et al., 1974) . The action of antioestrogens such as nafoxidine in depleting cytosol receptor has been shown by several groups (Rochefort et al., 1972a, b; Clark et al., 1974; Ruh & Ruh, 1974; Katzenellenbogen & Ferguson, 1975; Capony & Rochefort, 1975) . Inhibition of replenishment may be the main focus of the anti-oestrogenic action. In studies in the rat on the inhibitory action of nafoxidine in vivo much higher doses of nafoxidine than of oestradiol are generally used (references cited above). Indeed Jensen et al. (1972) suggest that 100-1000-fold greater doses of nafoxidine than of oestradiol are required to see substantial inhibition in vivo. In vitro the affinity of nafoxidine for the uterine-cytosol oestrogen receptor is one-thirtieth that ofoestradiol (Rochefort et al., 1972a, b) . Thus in the rat the anti-oestrogenic potency ofnafoxidine in vivo more or less reflects the relative affinity ofthe drug for the cytosol receptor. In the chick, however, the drug is much more potent 1977 than the affinity for the nuclear receptor in vitro might indicate. This difference in nafoxidine action, along with its lack of oestrogenic activity, and the absence of a typical cytosol receptor in chick liver underline a possible difference in the mechanism of oestradiol action in chick liver and the rat uterus. Sheridan (1975) has reviewed several other cases of steroidhormone action in which saturable nuclear binding of hormone is seen in the absence of classical cytosol receptor. It is possible, however, that cytosol receptor has escaped detection owing to instability. If such an activity is eventually found in the chick the nafoxidine results could imply that replenishment of cytosol receptor is required in the course of a primary response to oestradiol. This does not appear to be the case in the rat (Clark et al., 1974 
